Overview

Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer

Status:
Completed
Trial end date:
2019-10-03
Target enrollment:
Participant gender:
Summary
Study of Radium Ra 223 dichloride with enzalutamide compared to enzalutamide alone in men with metastatic castration refractory prostate cancer
Phase:
Phase 2
Details
Lead Sponsor:
University of Utah
Treatments:
Radium Ra 223 dichloride
Succinylcholine